Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2368 participants
OBSERVATIONAL
2018-01-01
2023-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Long-term Adverse Effects of Gastric Bypass in Omega
NCT04930029
Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric Surgery
NCT06794892
MINI Bypass Versus Roux-en-Y Bypass: Differences in HOrmonal Secretions at 2 Years of Surgery
NCT03482895
OAGB-MGB Conversions for Post-operative Complications
NCT04641715
One Anastomosis Gastric Bypass After Sleeve Gastrectomy Failure
NCT04450082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To better understand how often these problems occur, and whether they cause symptoms, the study follows patients for at least 5 years after surgery. All participants have an upper endoscopy (a camera test that looks at the esophagus, stomach, and the join with the small intestine) before surgery, and then again 1, 3, and 5 years afterwards. These check-ups are done even if the patient feels well, to detect any hidden changes early.
The study also compares what patients report in symptom questionnaires-covering issues like heartburn, regurgitation, or stomach discomfort-with what is actually seen during endoscopy. This will help doctors understand how well symptoms match the real condition of the digestive tract.
By using the same protocol across several specialized bariatric centers, and including all eligible patients, the study aims to provide reliable, long-term data to guide follow-up care after OAGB. The findings could help refine patient monitoring, improve early detection of problems, and identify risk factors that can be addressed to prevent complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets IFSO indications for bariatric surgery (BMI \> 40 kg/m², or BMI \> 35 kg/m² with obesity-related comorbidities).
* Candidate for primary one-anastomosis gastric bypass (OAGB).
* Preoperative upper endoscopy completed as part of standardized work-up.
* Helicobacter pylori screened preoperatively and (if positive) eradication therapy completed before surgery.
* Able and willing to attend scheduled postoperative upper endoscopies (at approximately 1, 3, and 5 years) regardless of symptoms.
* Able to complete patient-reported outcome instruments (GERD-HRQL and abbreviated GSRS).
* Provided written informed consent.
18 Years
67 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Sanitaria Locale Napoli 2 Nord
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francesco Pizza
MD,PhD, Responsible for the Bariatric and Metabolic Surgery unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
francesco pizza, PhD
Role: PRINCIPAL_INVESTIGATOR
Azienda Sanitaria Locale Napoli 2 Nord
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Sanitaria Locale Napoli 2 Nord - U.O.C. Chirurgia Generale, P.O. "Anna Rizzoli", Lacco Ameno, Naples, Italy
Naples, naples, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0923
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.